tm
Seeing Is Believing
tm
Seeing Is Believing
CMMB is currently covered by 2 analysts with an average price target of $14.28. This is a potential upside of $13.62 (2063.64%) from yesterday's end of day stock price of $0.66.
Chemomab Therapeutics Ltd DRC's activity chart (see below) currently has 3 price targets and 7 ratings on display. The stock rating distribution of CMMB is 80% BUY and 20% HOLD.
Highest price target for CMMB is $4, Lowest price target is $1, average price target is $14.28.
Most recent stock forecast was given by JAMES EDWARDES JONES from RBC on 07-Jun-2023. First documented stock forecast 07-May-2021.
Currently out of the existing stock ratings of CMMB, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
7
10 months 11 days ago
0/4 (0%)
$5.34 (321.69%)
Buy
30
2 years 4 months 8 days ago
0/1 (0%)
$21.89 (269.91%)
What is CMMB (Chemomab Therapeutics Ltd DRC) average time for price targets to be met?
Which analyst has the current highest performing score on CMMB (Chemomab Therapeutics Ltd DRC) with a proven track record?
Which analyst has the current lower performing score on CMMB (Chemomab Therapeutics Ltd DRC) with a proven track record?
Which analyst has the most public recommendations on CMMB (Chemomab Therapeutics Ltd DRC)?
Which analyst is the currently most bullish on CMMB (Chemomab Therapeutics Ltd DRC)?
Which analyst is the currently most reserved on CMMB (Chemomab Therapeutics Ltd DRC)?
